A review article published in the New England Journal of Medicine discusses the effects of alcohol use on various forms of liver disease, as well as the assessment and treatment of alcohol use in patients with the chronic liver disease.
All news from Anaesthesiology
A new study from researchers of CEDOC-NOVA Medical School and Instituto Gulbenkian de Ciência, led by Maria Paula Macedo and Carlos Penha-Gonçalves, respectively, showed that a molecule CD26/DPP-4 is involved in the regeneration of acute liver wounds and is a promising biomarker for hepatic disease.
Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) were significantly more likely to relapse than pediatric ALL patients, and factors including lower clinical trial enrollment and shorter duration of therapy were associated with relapse.
A public inquiry in Britain into a contaminated blood scandal dating back decades which left at least 2,400 people dead began Monday with a commemoration service and opening statements.
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) voted to recommend damoctocog alfa pegol (Jivi, Bayer AG) for the treatment and prophylaxis of bleeding in patients aged 12 years and older who have been previously treated for hemophilia A, a congenital factor VIII deficiency.
Antibiotics may be a feasible alternative to surgery for patients with uncomplicated acute appendicitis, 5-year follow-up data from a randomized trial show. Although appendectomy has been the mainstay of treatment for acute appendicitis for more than 100 years.
Researchers and scientists say new discoveries and drug creation could be beneficial to future astronauts on deep space missions. An international group of researchers has come up with a new plan to help astronauts survive high-level radiation in space and even get them to Mars without the deadly exposure expected during three years of space travel.
Higher inpatient pain scores and postoperative opioid consumption are associated with the persistent opioid use of up to six months among children and adolescents who have undergone cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. The study was published in a recent issue of Pediatric Anesthesia.
System eradicates unwanted cells rather than directly killing them. PEG-KYNase is an enzyme that researchers at the University of Texas are utilizing in a new effort to fight cancer. The enzyme doesn’t directly kill cancer cells; rather, it empowers the immune system to remove the unhealthy cells by its own enhanced functioning.
The study was published in a recent issue of Nature Biotechnology.
Scientists that we funded have identified a new source of stem cells which help to build blood vessels in the growing embryo. It changes scientific understanding of how blood vessels are made and brings scientists one step closer to using stem cells to grow new blood vessels and repair damaged ones. The study was published in today in Nature.